Keywords: Diffusion Analysis & Visualization, Diffusion Analysis and Visualization, breast cancer, treatment monitoring
Motivation: Diffusion-weighted imaging can be used to monitor treatment response in breast cancer. The conventional approach of measuring ADC requires manual processing and moderate predictive performance early in treatment.
Goal(s): To develop an objective measurement of diffusion response and evaluate its predictive performance.
Approach: Retrospective analyses were performed using data from the ACRIN 6698 trial. The restricted diffusion volume (RDV) was calculated by summing pixels meeting multiple objective criteria, including ADC in the range [0.6, 1.4] x10-3 mm2/s. The predictive performance of RDV was compared to conventional ADC and contrast-enhanced imaging.
Results: RDV outperformed ADC early in treatment and matched its performance post-treatment.
Impact: RDV is a novel, semi-automated diffusion metric that provides improved performance over conventional ROI-mean ADC. This can be used to optimize treatment and could lead to contrast-free therapy monitoring.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords